# FibriCheck Data Registry

Study · id `cardio:ct-nct06282393` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06282393](<https://clinicaltrials.gov/study/NCT06282393>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06282393

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT06282393. Allocation not applicable; no masking; primary purpose other. Start 2024-01-31 (actual); primary completion 2026-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT06282393, source copy `cardio:ctgov-nct06282393-2024-02-28`, retrieved 2026-10-26)
- Started: 2024-01-31 (actual) (ClinicalTrials.gov record NCT06282393, source copy `cardio:ctgov-nct06282393-2024-02-28`, retrieved 2026-10-26)
- Primary completion: 2026-02 (anticipated) (ClinicalTrials.gov record NCT06282393, source copy `cardio:ctgov-nct06282393-2024-02-28`, retrieved 2026-10-26)
- Completion: 2026-03 (anticipated) (ClinicalTrials.gov record NCT06282393, source copy `cardio:ctgov-nct06282393-2024-02-28`, retrieved 2026-10-26)
- Countries: Belgium (ClinicalTrials.gov record NCT06282393, source copy `cardio:ctgov-nct06282393-2024-02-28`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06282393-2024-02-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: FibriCheck Data Registry
- Acronym: FDR
- Condition: Cardiac Arrhythmia
- Intervention (Device): FibriCheck recordings
- Lead sponsor: Qompium NV
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry lists this organization as the lead sponsor: Qompium NV (`cardio:org-qompium-nv`)

## Provenance

Content hash: 2793d426870aa6deb6c82abd01c422811819114012c59690abd6ebf93d13fdd6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
